PhacoOptics Overview

  • Founded
  • 2009
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Series A
  • Investors
  • 1

PhacoOptics General Information

Description

Developer of a life-improving vision software designed to help in controlling the outcome of lens surgery. The company's vision software uses an algorithm to calculate optical conditions in connection with the implantation of the intraocular lens, enabling the ophthalmic lens surgeon to improve the refractive outcome of intraocular lens implantation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Outcome Management (Healthcare)
Other Industries
Other Healthcare Technology Systems
Primary Office
  • C/o Beierholm
  • Tangen 9
  • 8200 Aarhus
  • Denmark
+45 87 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PhacoOptics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC (Series A) Completed Startup
To view PhacoOptics’s complete valuation and funding history, request access »

PhacoOptics Executive Team (1)

Name Title Board Seat Contact Info
Thomas Olsen Ph.D Founder
To view PhacoOptics’s complete executive team members history, request access »

PhacoOptics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PhacoOptics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Capnova Venture Capital Minority 000 0000 000000 0
To view PhacoOptics’s complete investors history, request access »